A Pharmaceutical And Clinical Study of Kasisa Godanti Bhasma Capsule in Iron Deficiency Anaemia

A Pharmaceutical and Clinical Evaluation Of Kasisa Godanti Bhasma Capsule in the Management of Pandu Roga with Special Reference to Iron Deficiency Anaemia - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/11/076668

Enrollment

Registered

2024-11-12

Start date

Unknown

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D508- Other iron deficiency anemias

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients of age group 16 to 60 years irrespective of gender, religion, occupation 2)Patients having signs and symptoms of panduroga without any complications. 3)Haemoglobin percentage in between 7gm/dl to 11gm/dl. 4)Patients with samanaya lakshanaÂ ofÂ panduÂ roga

Exclusion criteria

Exclusion criteria: 1)Patients suffering from tuberculosis Diabetes mellitus or other severe disease.2)Age below 16 years and more than 60 years 3)Haemoglobin less than7gm/dl 4)Anemia due to causes other than iron deficiency like Thalassemia, Sickle cell anaemia Aplastic anaemia, Megaloblastic anaemia, anaemia due to bleeding disorders and Leukemia 5)Pregnant and lactatingÂ women.

Design outcomes

Primary

Measure	Time frame
Improvement in AnaemiaTimepoint: 15 Days,30 Days,45 Days	—

Secondary

Measure	Time frame
Complete Relief from AnaemiaTimepoint: 45 Days	—

Countries

India

Contacts

Public ContactDr Shweta Mishra

Government P.G Ayurvedic College and Hospital,Varanasi,Uttar Pradesh 221001

Richapathak384@GMAIL.COM8948883359

Outcome results